Charles River Laboratories | CRL - 普通股股本



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 13.56B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


普通股股本 更改 日
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 1000 2026-06
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.22M 282K 2026-03
Cardinal Health USD 235M 1000K 2026-03
Charles River Laboratories USD 47.73M 439K 2026-06
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 0 2025-12
CVS Health USD 1.28B 5M 2026-06
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Elevance Health USD 216.84M 528K 2026-06
Humana USD 120.08M 18K 2026-06
Illumina USD 151.3M 607K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
McKesson USD 116M 4M 2026-06
Merck EUR 434.78M 0 2026-03
Mettler Toledo International USD 20.21M 40.9K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Quest Diagnostics USD 110M 1000K 2026-06
Revvity USD 111.63M 174K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
United Therapeutics USD 42.68M 521K 2026-06
UnitedHealth USD 908.14M 468K 2026-06
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.19M 20K 2026-06
West Pharmaceutical Services USD 70.4M 500K 2026-06